Search Results - "Vicent, Carmen Herrero"

Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis by Blancas, Isabel, Linares-Rodríguez, Marina, Martínez de Dueñas, Eduardo, Herrero-Vicent, Carmen, Molero-Mir, María D., Garrido, José M., Rodríguez-Serrano, Fernando

“…Tamoxifen is a drug used for hormone receptor-positive breast cancers, primarily metabolised by the CYP2D6 enzyme into active metabolites such as endoxifen…”
Get full text

Machine Learning Models and Multiparametric Magnetic Resonance Imaging for the Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Herrero Vicent, Carmen, Tudela, Xavier, Moreno Ruiz, Paula, Pedralva, Víctor, Jiménez Pastor, Ana, Ahicart, Daniel, Rubio Novella, Silvia, Meneu, Isabel, Montes Albuixech, Ángela, Santamaria, Miguel Ángel, Fonfria, María, Fuster-Matanzo, Almudena, Olmos Antón, Santiago, Martínez de Dueñas, Eduardo

“…Background: Most breast cancer (BC) patients fail to achieve pathological complete response (pCR) after neoadjuvant chemotherapy (NAC). The aim of this study…”
Get full text

Breast cancer in pregnancy: an institutional experience by Blanquisett, Abraham Hernández, Vicent, Carmen Herrero, Gregori, Joaquín Gavilá, Zotano, Ángel Guerrero, Porta, Vicente Guillem, Simón, Amparo Ruiz

“…Breast cancer is one of the most common cancers diagnosed during pregnancy. Pregnancy-associated breast cancer (PABC) is defined as breast cancer diagnosed…”
Get full text

sQuiz your knowledge: multiple erythematous-violaceous plaques and nodules in a patient with acute myeloid leukaemia by Rivas-Tolosa, Nancy, Herrero-Vicent, Carmen, Llombart-Cussac, Beatriz

Get full text

Predictive and prognostic impact of tumour-infiltrating lymphocytes in triple-negative breast cancer treated with neoadjuvant chemotherapy by Herrero-Vicent, Carmen, Guerrero, Angel, Gavilá, Joaquin, Gozalbo, Francisco, Hernández, Abraham, Sandiego, Sergio, Algarra, Maria Asunción, Calatrava, Ana, Guillem-Porta, Vicente, Ruiz-Simón, Amparo

“…In locally and locally advanced triple-negative breast cancer (TNBC), neoadjuvant chemotherapy (NAC) only induces a pCR in 30-35% of patients. Clinical and…”
Get full text

Erratum: Diagnostic and therapeutic update of mantle cell lymphoma by Herrero-Vicent, Carmen, Machado, Isidro, Illueca, Carmen, Salazar, Claudia, Hernandez, Abraham, Sandiego, Sergio, Lavernia, Javier

Get full text

Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year by Herrero-Vicent, Carmen, Machado, Isidro, Illueca, Carmen, Avaria, Amparo, Salazar, Claudia, Hernandez, Abraham, Sandiego, Sergio, Lavernia, Javier

“…Mantle cell lymphoma (MCL) is an infrequent subtype of non-Hodgkin's lymphoma (NHL) and represents between 4-8% of adult lymphomas. Recently an increase in its…”
Get full text

Erratum: Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year by Herrero-Vicent, Carmen, Machado, Isidro, Illueca, Carmen, Avaria, Amparo, Salazar, Claudia, Hernandez, Abraham, Sandiego, Sergio, Lavernia, Javier

“…R-CHOP x six cycles, followed by rituximab (R) maintenance [14]” was repeated three times, whereas it should have only appeared once. On page 5, “However, it…”
Get full text